Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 153 clinical trials
Evaluating the Clinical Value of Traditional Chinese Medicine in the Adjuvant Therapy of Triple-negative Breast Cancer

This is a prospective, single site, randomized, double-blind Phase III clinical trial to evaluate the clinical value of Traditional Chinese Medicine in the adjuvant therapy of triple-negative breast cancer patients.

cancer
blood transfusion
oestrogen receptor
triple-negative breast cancer
neutrophil count
  • 0 views
  • 19 Feb, 2024
  • 1 location
Adjuvant Chemotherapy for Triple Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy

This study will evaluate the efficacy and safety of antharcycline-based adjuvant chemotherapy compared with observation in triple negative breast cancer (TNBC) patients with residual invasive disease after platinum and taxanes based neoadjuvant chemotherapy.

cancer
cyclophosphamide
residual tumor
immunomodulators
triple negative breast neoplasms
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study of the Efficacy and Safety of Camrelizumab Plus Radiotherapy for Patients With Early Triple-Negative Breast

This is a open-labeled, single-arm, Investigator-initiated clinical trial of camrelizumab (an anti-PD-1 antibody) in combination with radiotherapy in patients with early triple-negative breast cancer. We will enroll 60 subjects. This study aims to evaluate the efficacy and safety of camrelizumab combined with radiotherapy in the treatment of early TNBC

cancer
primary tumor
triple-negative breast cancer
absolute neutrophil count
neutrophil count
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Long Term Follow-Up Study of Fabry Disease Subjects Treated With FLT190

Current treatment for Fabry disease is limited to the symptomatic management of pain, conventional management of complications, and methods to increase the availability of functional GLA. This clinical study aims to investigate the long-term safety and durability of GLA in patients who have been dosed with a new gene therapy …

fabry's disease
glycosphingolipids
breakdown
deficiency
gene therapy
  • 0 views
  • 19 Feb, 2024
  • 1 location
Effectiveness and Acceptability of MINDFULNESS by Smartphone for Patients With Chronic Migraine and Medication Overuse

This preliminary study will be conducted on 25 patients that have been submitted to a withdrawal according to the standard procedure at our hospital and they will practice mindfulness daily by a standard session of 12 minutes on their smartphone recorded by the expert who generally manage their sessions at …

migraine
chronic migraine
therapeutic process
analgesia
  • 0 views
  • 19 Feb, 2024
  • 1 location
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

This research study involves testing the safety and efficacy of an investigational intervention for patients with triple-negative breast cancer (TNBC) that has spread, or metastasized, to other parts the body and is PD-L1-negative. The names of the study interventions involved in this study are: Sacituzumab govitecan (IMMU-132) Pembrolizumab (Keytruda; MK-3475)

cancer
neuropathy
programmed cell death 1 ligand 1
central nervous system disorder
immunomodulators
  • 8 views
  • 19 Feb, 2024
  • 1 location
NBE-002 in Patients With Advanced Solid Tumors

This first-in-human study will evaluate the recommended dose for further clinical development, safety, tolerability, anti-tumor activity, immunogenicity, pharmacokinetics and pharmacodynamics of NBE-002, a novel anti-ROR1 antibody-drug conjugate, in patients with advanced solid tumors.

cancer
solid neoplasm
triple-negative breast cancer
carcinoma
solid tumour
  • 0 views
  • 19 Feb, 2024
  • 2 locations
Ipatasertib + Atezolizumab to Prevent Recurrence in TNBC

The purpose of this study is to determine if a combination of two drugs ipatasertib and atezolizumab works as a treatment for residual cancer in the breast or lymph nodes and have circulating tumor DNA in the blood. This research study involves the following investigational drugs: Ipatasertib Atezolizumab

cancer
immunomodulators
serum bilirubin
menstrual period
absolute lymphocyte count
  • 0 views
  • 19 Feb, 2024
  • 1 location
Strain vs. Left Ventricular Ejection Fraction-based Cardiotoxicity Prevention in Breast Cancer

Comparing preventive effect of myocardial global longitudinal strain-based cardioprotective stragety (angiotensin receptor blocker prophylaxis) with left ventricular ejection fraction-based strategy in breast cancer patients treated with adjuvant trastuzumab.

cancer
ejection fraction
immunomodulators
HER2
her2/neu-positive breast cancer
  • 0 views
  • 19 Feb, 2024
  • 1 location
Radiotherapy 3 vs 6 Gy in Gonarthrosis and Coxarthrosis

Once the treatment is finished, patients will be assessed at 8 weeks. If pain does not improve, a re-irradiation will be performed. If the patients were treated with 3 Gy a new randomization will be performed (3 vs 6 Gy again).

osteoarthritis
  • 0 views
  • 19 Feb, 2024
  • 1 location